Captozyme

Captozyme

Captozyme

Captozyme is a preclinical stage biotechnology company dedicated to the enhancement of foods to reduce intake of oxalate.
Founded
2009
Raised
$3.4M
Follow us
Alexa global traffic share
Latest funding
$3,400,000
Venture capital (Series A) - 2017
Team Size
10+
Employees
$3,400,000 Venture capital (Series A)
prnewswire

Captozyme Secures $3.4 Million to Continue Enzyme Research